Metraipolis › archive › dc_2aa2aee052bb

Nanoparticle-boosted myeloid-derived suppressor cell therapy for immune reprogramming in multiple sclerosis — Europe PMC PMID:41091873

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41091873
DOI: 10.1126/sciadv.ady4135
License (as archived): solo-consultazione
Archived: 2026-11-09T07:35:12.513Z
SHA-256 of the archived text: 10cf87d6016a06f70f8d579884264f896cca3d3a6baccf52b16ead37b9b78181
Stable URL of this page: https://metraipolis.com/documento/dc_2aa2aee052bb

How to cite

Nanoparticle-boosted myeloid-derived suppressor cell therapy for immune reprogramming in multiple sclerosis — Europe PMC PMID:41091873 — Europe PMC (en), https://europepmc.org/article/MED/41091873 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2aa2aee052bb (Metraipolis archive dc_2aa2aee052bb, sha256 10cf87d6016a06f70f8d579884264f896cca3d3a6baccf52b16ead37b9b78181)

BibTeX

@misc{dc2aa2aee052bb,
  title = {Nanoparticle-boosted myeloid-derived suppressor cell therapy for immune reprogramming in multiple sclerosis — Europe PMC PMID:41091873},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41091873},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2aa2aee052bb; sha256 10cf87d6016a06f70f8d579884264f896cca3d3a6baccf52b16ead37b9b78181},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41091873. Agents can read the archived copy with the MCP tool read_document.